Bharat Forge Limited’s Board of Directors has approved a substantial further investment of up to ₹2,400 million in its wholly-owned subsidiary, Kalyani Strategic Systems Limited (KSSL). This investment, to be made at fair value in one or more tranches, aims to support KSSL’s operations and growth within the defense industry. The move is expected to strengthen the subsidiary’s position and contribute to the company’s overall strategic objectives in this sector. The investment is anticipated to be completed by March 31, 2027.
Bharat Forge Approves Major Subsidiary Investment
In a significant strategic move, the Board of Directors of Bharat Forge Limited has given its approval for a further investment of up to ₹2,400 million (approximately $240 crore) in its wholly-owned subsidiary, Kalyani Strategic Systems Limited (KSSL). This decision, made during a board meeting on August 10, 2026, underscores the company’s commitment to strengthening its presence and capabilities within the defense sector.
Details of the Investment
The investment will be made at fair value and can be executed in one or more tranches. KSSL is a public limited company engaged in the developing and manufacturing of defense platforms, systems, and equipment, serving both Indian and global markets. For the Financial Year 2025-26, KSSL reported a turnover of Rs. 12,244.70 million. This investment is considered a Related Party Transaction, and it will be conducted on an arm’s length basis, with no interest from Bharat Forge’s promoter or promoter group companies in this specific investment.
Strategic Rationale and Future Outlook
The proposed investment is in furtherance of KSSL’s main line of business, the defense industry, and is intended to enable KSSL to make further investments in its own operations. This proactive financial infusion is expected to enhance KSSL’s capacity for product development, manufacturing, and market expansion. The company anticipates that the investment will be fully completed on or before March 31, 2027. No governmental or regulatory approvals are required for these transactions, indicating a streamlined process for this strategic capital allocation.
Source: BSE
